CHISON MEDICAL(SH:688358) Sou Hu Cai Jing·2026-01-30 12:05Group 1 - The core viewpoint of the article highlights the recent performance and financial metrics of Xiangsheng Medical (688358), indicating a slight increase in stock price and mixed financial results for the third quarter of 2025 [1][2]. Group 2 - As of January 30, 2026, Xiangsheng Medical's stock closed at 36.62 yuan, with a 0.33% increase, a turnover rate of 1.09%, and a trading volume of 12,200 hands, resulting in a transaction amount of 44.32 million yuan [1]. - In terms of capital flow on January 30, 2026, the net outflow of main funds was 597,900 yuan, accounting for 1.35% of the total transaction amount, while retail investors saw a net inflow of 2.84 million yuan, representing 6.41% of the total transaction amount [1]. Group 3 - For the first three quarters of 2025, Xiangsheng Medical reported a main revenue of 343 million yuan, a year-on-year decrease of 5.27%, and a net profit attributable to shareholders of 93.92 million yuan, down 4.56% year-on-year [2]. - The third quarter of 2025 showed a single-quarter main revenue of 107 million yuan, down 6.68% year-on-year, but a net profit attributable to shareholders increased by 41.95% to 24.22 million yuan [2]. - The company has a debt ratio of 11.24%, with investment income of 3.01 million yuan and financial expenses of -16.53 million yuan, while maintaining a gross profit margin of 59.82% [2]. Group 4 - In the last 90 days, three institutions have given buy ratings for Xiangsheng Medical, indicating positive sentiment among analysts [3].